The Lancet Gastroenterology & Hepatology
Fecha de publicación: 17 July 2019
Autores: Olga C Aroniadis, MD., Prof Lawrence J Brandt, MD., Caterina Oneto, MD., Paul Feuerstadt, MD., Alex Sherman, MD., Prof Allan W Wolkoff, MD., et al.
Background: Faecal microbiota transplantation (FMT) has shown promise in alleviating the symptoms of irritable bowel syndrome (IBS); however, controlled data on this technique are scarce. The aim of this clinical trial was to assess the efficacy of FMT in alleviating diarrhoea-predominant IBS (IBS-D).Leer más